SEC charges ex-Gold­man Sachs an­a­lyst with il­le­gal­ly prof­it­ing off bio­phar­ma merg­ers in in­sid­er trad­ing scheme

A for­mer com­pli­ance an­a­lyst abused his ac­cess to con­fi­den­tial and non-pub­lic in­for­ma­tion to il­le­gal­ly prof­it off of dozens of merg­ers and SPAC deals, in­clud­ing sev­er­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER